Evidence map›Paper›PMID 39910970›Full record

SynthesisRevista de neurologia2025

[Cognition and Long COVID: A PRISMA Systematic Review of Longitudinal Studies].

María Alejandra Tudorache Pantazi, Marien Gadea-Doménech, Raúl Espert Tortajada

Abstract readSystematic ReviewEnglish Abstract
In one paragraph

Synthesis in Revista de neurologia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

María Alejandra Tudorache PantaziUnidad de Neuropsicología (Servicio de Neurología), Hospital Clínico Universitario de València, 46010 Valencia, España.
Marien Gadea-DoménechDepartamento de Psicobiología, Facultad de Psicología, Universitat de València, 46010 València, España.
Raúl Espert TortajadaUnidad de Neuropsicología (Servicio de Neurología), Hospital Clínico Universitario de València, 46010 Valencia, España.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionLong COVID is defined by National Institute for Health and Care Excellence (NICE) as the set of signs and symptoms that develop during or after a SARS-CoV-2 infection and continue for more than twelve weeks without any alternative diagnosis. One of the most frequent persistent symptoms reported by patients and verified in neuroimaging studies is cognitive dysfunction, due to a generalized hypoconnectivity and a diffuse axonal lesion in white matter. Therefore, the objectives of the present review are to determine how long cognitive functions remain affected during Long COVID and to explore which cognitive functions are most affected beyond three months of follow-up in patients up to 65 years of age without previous neuropsychological or psychiatric complications.

methodsA systematic review was performed using PRISMA criteria and 11 articles were included through a comprehensive search of five different databases: PubMed, Medline, Scopus, WOS and ProQuest. The risk of bias of the articles was assessed using the Newcastle-Ottawa scale.

resultsCognitive problems in Long COVID persist over time and improve slowly, although studies seem to agree that most areas improved significantly after one year. The cognitive functions that remained impaired the longest were processing speed and attention.

conclusionsThese cognitive alterations cause a reduction in the quality of life of the patients and a reduction in work capacity and manifest the need for a cognitive intervention.

Indexed as

CognitionCognitive DysfunctionCOVID-19HumansLongitudinal StudiesPost-Acute COVID-19 SyndromeTime FactorscognitionCOVID-19Long COVIDlongitudinal studiesSARS-CoV-2systematic review

Identifiers

PMID39910970
PMCPMC11799851

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.